Evaluation of Two Protocol of Maxillary Protraction in Class III Adolescent After Using (MSE)
Launched by AL-AZHAR UNIVERSITY · Aug 4, 2022
Trial Information
Current as of April 29, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different methods of maxillary protraction, which is a treatment to help improve the position of the upper jaw (maxilla) in adolescents with a specific dental issue called Class III malocclusion. The trial compares a newer technique called Alt-RAMEC with a traditional method known as rapid palatal expansion. By using advanced imaging technology (cone beam computed tomography or CBCT), the researchers want to see which method is more effective in helping these young patients who have problems such as a collapsed upper jaw or misaligned teeth.
To be eligible for this study, participants should be adolescents experiencing specific issues like a retrognathic maxilla (where the upper jaw is positioned further back than the lower jaw), cross-bites, or similar dental alignments, and they should not have had any previous orthodontic treatments. They should also be in good overall health with no diseases that could affect their treatment. Participants in this trial will receive either of the two treatment methods, and the results will help improve future orthodontic care for similar cases. It's important to note that this trial is currently active but not recruiting new participants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Class3 Patients suffering maxillary collapse with a skeletal background
- • Patients with retrognathic maxilla.
- • Patients with anterior cross-bite or incisor end-to-end relationship
- • Patients with unilateral or bilateral posterior crossbite.
- • Patients with no periodontal disease.
- • Patients with good oral hygiene and general health.
- • No systemic diseases that may affect bone quality or interfere with orthodontic treatment.
- • Patients with no previous orthodontic treatment.
- Exclusion Criteria:
- • previous orthodontic treatment.
- • Craniofacial syndrome.
About Al Azhar University
Al-Azhar University, a prestigious institution in Egypt, is dedicated to advancing medical research and education through rigorous clinical trials. With a strong emphasis on ethical standards and scientific integrity, the university aims to contribute to the development of innovative therapies and healthcare solutions. By fostering collaboration among researchers, healthcare professionals, and academic experts, Al-Azhar University positions itself as a leading sponsor in clinical research, committed to improving patient outcomes and enhancing the understanding of various medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, Nasr City, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials